Can-Fite BioPharma American Depositary Shares
CANF
11 hedge funds and large institutions have $262K invested in Can-Fite BioPharma American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
8% less funds holding
Funds holding: 12 → 11 (-1)
31% less capital invested
Capital invested by funds: $380K → $262K (-$118K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$9.62K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$310 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$22K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.6K |
| 3 |
Morgan Stanley
New York
|
-$12.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.67K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $187K | -$12.1K | -78 | -5% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $20.1K | -$20.6K | -133 | -45% |
|
3
Fifth Third Bancorp
Cincinnati,
Ohio
| $18.4K | – | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $16.5K | +$9.62K | +62 | +85% |
|
5
Stifel Financial
St. Louis,
Missouri
| $7.36K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $5.31K | -$6.67K | -43 | -49% |
|
7
National Bank of Canada
Montreal,
Quebec, Canada
| $3.67K | – | – | – |
|
8
Citigroup
New York
| $3.39K | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $327 | – | – | – |
|
|
10
BNP Paribas Financial Markets
Paris,
France
| $245 | +$310 | +2 | New |
|
|
TWC
11
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $164 | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$22K | -144 | Closed |
|
CANF Hedge Fund Activity: Q4 2022 in Review
11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2022, worth a combined $262K — down 31% from $380K a quarter earlier.
Fund positioning in CANF was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Two Sigma Securities, adding an estimated $9.62K. The largest seller was Virtu Financial, exiting entirely with an estimated $22K sold.
- 11 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2022, down from 12 in Q3 2022.
- Funds reported $262K of Can-Fite BioPharma American Depositary Shares stock for Q4 2022, down 31% quarter-over-quarter.
- 1 fund opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2022 was Two Sigma Securities, an estimated $9.62K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2022 was Virtu Financial, an estimated $22K sold.
Based on aggregated 13F filings for Q4 2022.